mildy silly article below, on HUFFINGTON POST,  about how Pres. Bush and the Wall St. mess will diminish HBS ‘brand”. Nothing serious here but  perhaps an indicator of early anti-Business School backlash. There is cert. pitchfork fury out there about Wall St. meltdown (count ME in) and if you are  smart but unfocused pup just about to graduate, or recent grad.,  and choice is  between law or business school, you might start tilting towards law.

As to Bush sullying the HBS brand? Fact is, that Bush never was really heavily identified w. HBS (and did not choose much staff from there) but Obama is connected to Havard Law School,and will have MANY cabinet, etc. picks fr. HLS and Yale –so the buzz might start tilting towards law school, same way it did during Watergate. Also, how many college seniors are heading for Goldman, Lehmann, Morgan, Bear etc. next year???? That has got to dry up the B school pipeline, and tip some kids to law school as well.  And if you start seeing Wall St. perp walks next year (again, count me in!!!), well, more brain power off to Law School, as all of a sudden being a Tiger Prosecutor starts looking like lot a lot fun. [It actually IS! I was a prosecutor. altho no tiger, but even hanging out w. the cops and nailing drunk drivers was fun!]

(more…)

ha, ha, he may be getting achievement burnout fr. all the superstars he admits.  Full story, in Careers section of WSJ, typical sociological froth.

http://online.wsj.com/article/SB122455219391652725.html

“They really do seem to want everything, and I can’t decide if it’s an inability or an unwillingness to make trade-offs,” says Derrick Bolton, assistant dean and M.B.A. admissions director at Stanford University’s Graduate School of Business. “They want to be CEO, for example, but they say they don’t want to give up time with their families.”

OK, SOME OTHER YOUNGSTERS HBS HAS TAKEN –MOST OF THESE GEEZERS ARE OVER 28 FROM THE LOOK OF IT.
ALSO, IN CASE YOU WERE WONDERING WHO THE OVER 30 IS??????

Harvard Business School Names

New Life Sciences Fellows

BOSTON, Sept. 17, 2008 — Harvard Business School (HBS) announced today the first winners of its Life Sciences Fellowships. The Fellowship Program, established by the School in January 2008, awards $20,000 each to ten incoming MBA students with outstanding credentials from various disciplines in the life sciences.  . . . .The following members of the MBA Class of 2010 have received Life Sciences Fellowships:

• Mike Derse comes to HBS with eight years of experience in engineering research and medical devices. Most recently, he worked at Aqueduct Medical, where he managed the development and release of a product that reduces pain, swelling, and recovery time after cosmetic and other types of surgery. During a fellowship at Stanford, where he earned a master’s and bachelor’s degree in mechanical engineering, he invented a method for bonding thin film plastics used in drug delivery. After receiving his MBA degree from HBS, he aims to start a medical device company.
• Shawn Anthony is in the fourth year of Harvard’s joint MD/MBA program. As an undergraduate at Northwestern University, he worked on innovative nanotechnology applications in medicine, including nanofiber gels for stem cell delivery and tissue regeneration. He has conducted clinical research at Boston’s Brigham and Women’s Hospital, where he evaluated the performance of orthopedic implants and the cost-effectiveness of a diabetes management service for critically ill patients. He recently completed a management internship at Massachusetts General Hospital, where he developed strategies to improve healthcare delivery. He plans to use his interdisciplinary background in engineering, medicine, and business to pursue roles as a physician and healthcare entrepreneur.
• Christian Hordo conducted brain tumor research at the Hospital for Sick Children as a graduate student in the Department of Medical Genetics and Microbiology at the University of Toronto. His work improved understanding of the fate of neural cells during brain tumor formation and offered potential insights for the development of future targeted cancer therapies. As an undergraduate at McGill University, he was an honors researcher at the Montreal Neurological Institute, investigating areas such as genetic mapping and brain development during infancy. He plans to work in biotechnology management or venture capital, assessing the potential of therapeutics in oncology and related fields.
• Before entering HBS, Karthik Ranganathan was a research scientist at PocketSonics, Inc., where he played a leading role in developing an inexpensive and portable diagnostic ultrasound imaging system. While at the company, he also was a visiting research scientist in the University of Virginia’s Department of Electrical and Computer Engineering. Before joining PocketSonics, he earned a doctorate in biomedical engineering from the University of Virginia. After receiving his MBA, Ranganathan would like to gain business experience at a healthcare-related firm and, ultimately, establish a venture to develop affordable solutions to pressing problems in healthcare.
• Tara Dunn has been immersed in healthcare and science for the past 11 years. She graduated cum laude in biology from Harvard University, then earned a master’s degree in drug regulatory affairs and health policy from the Massachusetts College of Pharmacy and Health Sciences. She most recently worked in the healthcare strategy consulting and medical device industries. As manager of clinical and regulatory affairs at InfraReDx, Inc., from 2002 to 2005 she played a key role in obtaining first authorization for the company to sell its innovative coronary catheter in the United States.
• Alok Sathaye spent the last two years as a healthcare strategy consultant at Heath Advances, helping develop strategies to bring early-stage technologies in medical imaging, medical devices, and pharmaceuticals to market. Previously, he was a senior research scientist at Guidant and Boston Scientific, where he helped develop features for new pacemaker and implantable defibrillator devices through preclinical and clinical studies. He has coauthored numerous articles in major cardiology journals, and filed many patents for device-based medical therapies in the United States and Europe. He holds bachelor’s and master’s degrees in biomedical engineering from the Johns Hopkins University.
• Madhav Vasanthavada worked for more than four years in research and development at Novartis Pharmaceuticals Corporation. One of his major contributions was to develop and implement an innovative manufacturing technology that helped Novartis launch a new treatment for patients with type 2 diabetes. With a Ph.D in pharmaceutical sciences from the University of Rhode Island, he has published articles in scientific publications, filed patents for novel approaches to drug product development, and delivered invited presentations at pharmaceutical conferences. His career goal is to leverage his scientific and business leadership skills to drive pharmaceutical innovation.
• James McNally has focused on the biomedical optics field-namely, the use of light in medical diagnostic and therapeutic applications. Prior to HBS, he worked at Boston Scientific, developing endoscopic imaging systems for gastrointestinal and urological medical devices. He most recently was involved in the formation of a start-up commercializing an optics-based cancer therapy system. McNally earned an M.S. in optical sciences from the University of Arizona, where he researched the development of advanced imaging and spectroscopy tools for the study of cancer and heart disease. He graduated magna cum laude in electrical engineering from Princeton University.
• Sean Murray worked as a design engineer on a promising new surgical suction device at orthopedic manufacturer Stryker Corporation, where his research and development team was recognized as the company’s best in 2007. At Stryker, he also led a design team that produced a line of patent-pending disposable manifolds. Murray graduated as valedictorian of the University of New Mexico’s School of Engineering, and was one of 77 students in the United States awarded a Truman Scholarship in 2004 for leadership potential. He hopes to pursue a general management career in medical devices and biotechnology upon graduation.
• Ray Liu earned his master’s degree from the University of California, Berkeley, while conducting advanced research in DNA sensing to detect genetic and parasitic diseases. Before entering HBS, he worked at GE Healthcare, with roles in research, engineering, and project management. He spent the past two years in China, helping develop a global quality management system for the company’s new rural markets business, which provides vital-sign monitors for patients in developing countries. He plans to continue working in global healthcare development, focusing his HBS studies on international business and social enterprise.
• Antonio Perez is a Harvard MD/MBA joint-degree candidate. A Phi Beta Kappa graduate of Harvard College, he most recently finished a clinical year at Massachusetts General Hospital, where he had previously completed a management internship in the office of the hospital’s president. His published research has focused on developing stem cell therapies for muscle diseases such as muscular dystrophy. A former Paul and Daisy Soros Fellow and Howard Hughes Medical Institute research fellow, he is interested in pursuing cardiology and healthcare administration. Ultimately, he aims to serve as president of a leading academic hospital system.
  

HBS AND AGE JIHAD.

FROM HER MAJESTY’S BLOG. FIRST OFF, THANK YOU, YOUR MAJESTY, NOTHING LIKE GIVING THE PEOPLE THE FACTS AND LETTING THEM DRAW THEIR OWN CONCLUSIONS. WE AWAIT SIMILAR CHARTS FOR GPA AND GMAT SCORES. LIKE WHAT IS SO HARD ABOUT THAT? KELLOGG ACTUALLY USED TO DO SOMETHING SIMILAR FOR GMATS, AND IT WAS VERY HELPFUL. I KNOW WHAT YOU’RE SAYING, “HEY, PUTZ, I GAVE YOU THIS, AND ALL YOU CAN DO IS ASK FOR MORE?” WELL, THAT IS  WHAT TRANSPARENCY DOES TO PEOPLE. MAKES ‘EM WANT MORE, LIKE FREEDOM. BUT P.S. THANKS AGAIN. I APPRECIATE IT, KEEP UP THE GOOD WORK.

OK, WHAT WE GOT HERE IS 102 ACCEPTS FR. CLASS OF 2002 + PRIOR, AND MY GUESS IS, IF YOU TAKE OUT WEST POINT AND USNA AND USAFA  SERVICE ACADEMY GUYS (TYPICALLY 40 OR SO) AND OTHER MILITARY TYPES (ANOTHER 15-20) YOU COULD HAVE BASICALLY ~50 ACCEPTS WHO ARE 28+ [SERVICE ACADEMY GUYS COMMIT TO FIVE YEARS, IN THEORY IF YOU GRAD IN 2003, YOU WOULD DISCHARGE IN 2008 AND COULD HAVE APPLIED FOR SEPT 2008 INTAKE, SOMEONE IN MILITARY CHECK ME ON THIS]. THAT IS A PRETTY SLIM NUMBER. ONCE YOU GET TO 29, 30 AND OVER……………..MAN, YOU ARE TALKING LIKE 50 PEOPLE, SOME 20 OR SO OF WHOM COULD BE  MEDICAL DOCS OR PH.D’S. THE NUMBER OF NON-MILITARY, NON-PHD, NON-DOCS IS REALLLLLLLLLLLLY SMALL. BUT ALL THAT SAID, I GUESS IT DOES HAPPEN. MY GUESS IS, INTERNATIONALS, FOREIGN MILITARY W. REQ. SERVICE [ISRAEL, SINGAPORE, TAIWAN, SWITZERLAND, ETC. ] AND YES, MAYBE 4 INDIAN I.T. GUYS, SPREAD OUT ALL OVER GOD’S GREEN EARTH.

Here’s a breakdown of when the Class of 2010 graduated from college/university by class year. Remember, all directly admitted college seniors have the option to postpone matriculation in order to gain work experience.